Affimed GmbH
Technologiepark
Im Neuenheimer Feld 582
Heidelberg
69120
Germany
Tel: 49-6221-65307-0
Fax: 49-6221-65307-77
Website: http://www.affimed.com/
Email: info@affimed.com
169 articles about Affimed GmbH
-
Affimed Therapeutics AG To Present At Noble Financial Capital Markets' 12th Annual Investor Conference
1/12/2016
-
Affimed Therapeutics AG Announces Appointment Of Andrew Curtis To Lead Corporate Strategy And Business Development, Expansion Of US Presence
12/2/2015
-
Affimed Therapeutics AG To Present At The Oppenheimer 26th Annual Healthcare Conference -- New York
12/1/2015
-
Affimed Therapeutics AG CEO To Present At The Jefferies 2015 Global Healthcare Conference -- London
11/11/2015
-
Affimed Therapeutics AG Reports Financial Results For Third Quarter 2015
11/10/2015
-
Affimed Therapeutics AG Presents Data On Potency Of NK- And T-Cell Egfrviii Tandabs At SITC
11/6/2015
-
Affimed Therapeutics AG To Present Data On NK- And T-Cell Engagers At American Society of Hematology
11/5/2015
-
Affimed Therapeutics AG Announces Significant Investment By An Existing Shareholder
10/15/2015
-
Affimed Therapeutics AG To Present Data On Potency Of NK- And T-Cell Egfrviii Tandabs At SITC
10/6/2015
-
Affimed Therapeutics AG To Present At The Leerink Partners Inaugural Immuno-Oncology Roundtable Conference
9/23/2015
-
Affimed Therapeutics AG Announces Second Quarter 2015 Financial Results And Corporate Update Conference Call
7/28/2015
-
Affimed Therapeutics AG Added To Russell 2000(R) Index
6/30/2015
-
Affimed Therapeutics AG Announces Newly Formed Scientific Advisory Board
6/3/2015
-
ASCO15: Affimed Therapeutics AG ASCO Data For The CD33/CD3-Tandab Program Demonstrate That CD33 And CD3 Binding Affinities Correlate With Potent T-Cell Activation And Cytotoxicity
5/29/2015
-
ASCO15: Affimed Therapeutics AG ASCO Data Demonstrate Consistent Potency of NK-Cell-Engaging Combination Therapy with Checkpoint Modulators
5/29/2015
-
Affimed Therapeutics AG Reports Financial Results For First Quarter 2015
5/21/2015
-
Affimed Therapeutics AG Announces First Quarter 2015 Financial Results Conference Call
5/13/2015
-
Affimed Therapeutics AG Announces Pricing Of Public Offering Of Common Stock
5/7/2015
-
Affimed Therapeutics AG Announces Proposed Public Offering Of Common Stock
5/4/2015
-
Affimed Therapeutics AG Announces Financial Results For Fourth Quarter And Year End 2014
3/25/2015